Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children

Zheng Liu, Mette Julsgaard*, CARINA Study Group , Xiao Zhu, Jennifer Martin, Murray L. Barclay, Noel Cranswick, Peter R. Gibson, Richard B. Gearry, Janine van der Giessen, Susan J. Connor, Ourania Rosella, Anne Grosen, Catherine Toong, Emma Flanagan, Jantien W. Wieringa, C. Janneke van der Woude, Sally J. Bell

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science